Primer: Molecular tools used for the understanding of endocrinology

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 4, 2007, Pages 355-368

  Kopchick, John J ^a,b   Sackmann Sala, Lucila ^a   Ding, Juan ^a  

^a OHIO UNIVERSITY   (United States)

^b OHIO UNIVERSITY   (United States)

Author keywords

Blotting; Gene cloning; Molecular techniques; PCR; Transgenic animals

Indexed keywords

DNA; GENE PRODUCT; PROTEIN; RNA;

ENDOCRINE DISEASE; GENETIC MANIPULATION; GENOMICS; HUMAN; METABOLISM; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHERN BLOTTING; TRANSGENIC ANIMAL; WESTERN BLOTTING;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CLONING, MOLECULAR; DNA; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; ENDOCRINOLOGY; HUMANS; MOLECULAR BIOLOGY; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 33947541841     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0446     Document Type: Review

References (79)

1. Ausubel FM et al. (2005) Current Protocols in Molecular Biology. (Ed. Harkins EW) New York: John Wiley & Sons
2. Sambrook J and Russel DW (2001) Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press
3. Lodish H et al. (2004) Molecular Cell Biology. New York: WH Freeman and Company
4. Lewin B (2004) Genes VIII. New Jersey: Pearson Prentice Hall
5. Golemis EA and Adams PD (2005) Protein-Protein Interactions: A Molecular Cloning Manual. New York: Cold Spring Harbor Laboratory Press
6. Cooper G (2000) The Cell: A Molecular Approach. Washington DC: ASM Press
7. Soulet D and Rivest S (2002) Perspective: how to make microarray, serial analysis of gene expression, and proteomic relevant to day-to-day endocrine problems and physiological systems. Endocrinology 143: 1995-2001
8. International Human Genome Sequencing Consortium (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921
9. Venter JC et al. (2001) The sequence of the human genome. Science 291: 1304-1351
10. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome. Nature 431: 931-945
11. Birney E et al. (2006) Ensembl 2006. Nucleic Acids Res 34: D556-D561
12. Ast G (2005) The alternative genome. Sci Am 292: 40-47
13. Service RF (2001) Proteomics. High-speed biologists search for gold in proteins. Science 294: 2074-2077
14. DeNoto FM et al. (1981) Human growth hormone DNA sequence and mRNA structure: possible alternative splicing. Nucleic Acids Res 9: 3719-3730
15. Zhan X et al. (2005) Proteomics analysis of growth hormone isoforms in the human pituitary. Proteomics 5: 1228-1241
16. Southern E (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503-517
17. Alwine JC et al. (1977) Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci USA 74: 5350-5354
18. Towbin H et al. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354
19. Tiong JDR et al. (2006) A liver specific gene that is expressed in growth hormone transgenic mice and in normal female mice as a function of age. Growth Horm IGF Res 16: 145-156
20. Bartlett JMS (2002) Approaches to the analysis of gene expression using mRNA. Mol Biotechnol 21: 149-160
21. Wacker MJ and Godard MP (2005) Analysis of one-step and two-step real-time RT-PCR using SuperScript III. J Biomol Tech 16: 266-271
22. Cheng S et al. (1994) Effective amplification of long targets from cloned inserts and human genomic DNA. Proc Natl Acad Sci USA 91: 5695-5699
23. Pandey A and Mann M (2000) Proteomics to study genes and genomes. Nature 405: 837-846
24. Tefferi A et al. (2002) Primer on medical genomics. Part II: background principles and methods in molecular genetics. Mayo Clin Proc 77: 785-808
25. Commercial and Academic Arrays Available in ArrayExpress [http://www.ebi.ac.uk/~ele/tables/ Commercial_academic.htm] (accessed 11 January 2007)
26. Peeters JK and Van der Spek PJ (2005) Growing applications and advancements in microarray technology and analysis tools. Cell Biochem Biophys 43: 149-166
27. Khochbin S et al. (1991) Multiple control level governing H10 mRNA and protein accumulation. FEBS Lett 283: 65-67
28. Rousseau D et al. (1992) Induction of H1(0)-gene expression in B16 murine melanoma cells. Eur J Biochem 208: 775-779
29. Anderson L and Seilhamer J (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18: 533-537
30. Lockhart DJ and Winzeler EA (2000) Genomics, gene expression and DNA arrays. Nature 405: 827-836
31. Marshall E (2004) Getting the noise out of gene arrays. Science 306: 630-631
32. Vissers LELM et al. (2005) Identification of disease genes by whole genome CGH arrays. Hum Mol Genet 14: R215-R223
33. Speicher MR and Carter NP (2005) The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet 6: 782-792
34. Couzin J (2006) Genomics. The HapMap gold rush: researchers mine a rich deposit. Science 312: 1131
35. Chakravarti A (2001) To a future of genetic medicine. Nature 409: 822-823
36. van Heemst D et al. (2005) Variation in the human TP53 gene affects old age survival and cancer mortality. Exp Gerontol 40: 11-15
37. McKay JA et al. (2001) Distinct differences in a cyclin D1 single nucleotide polymorphism between ethnic groups. Gene Screen 1: 139-142
38. Kumar A et al. (2005) A haplotype of the angiotensinogen gene is associated with hypertension in African Americans. Clin Exp Pharmacol Physiol 32: 495-502
39. Human Genome Project Information [http://www.ornl. gov/sci/techresources/ Human_Genome/home.shtml] (accessed 11 January 2007)
40. International HapMap Project [http://www.hapmap.org/] (accessed 11 January 2007)
41. The SNP Consortium Ltd [http://snp.cshl.org/] (accessed 11 January 2007)
42. Hodgson J and Marshall A (1998) Pharmacogenomics: will the regulators approve? Nat Biotechnol 16: 243-246
43. Pantel J et al. (2000) Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem 275: 18664-18669
44. Jorge AAL et al. (2006) Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. J Clin Endocrinol Metab 91: 1076-1080
45. Dos Santos C et al. (2004) A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36: 720-724
46. Blum WF et al. (2006) The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH receptor. J Clin Endocrinol Metab 91: 4171-4174
47. Kopchick JJ et al. (2002) Perspective: proteomics - see "spots" run. Endocrinology 143: 1990-1994
48. ExPASy Proteomics Server [http://www.expasy.org/] (accessed 11 January 2007)
49. Yates JR III et al. (2005) Proteomics of organelles and large cellular structures. Nat Rev Mol Cell Biol 6: 702-714
50. Fields S and Song O (1989) A novel genetic system to detect protein-protein interactions. Nature 340: 245-246
51. Sørensen HP and Mortensen KK (2005) Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol 115: 113-128
52. Walsh G (2005) Therapeutic insulins and their largescale manufacture. Appl Microbiol Biotechnol 67: 151-159
53. Court DL et al. (2002) Genetic engineering using homologous recombination. Annu Rev Genet 36: 361-388
54. Marsischky G and LaBaer J (2004) Many paths to many clones: a comparative look at high-throughput cloning methods. Genome Res 14: 2020-2028
55. Hartley JL et al. (2000) DNA cloning using in vitro site-specific recombination. Genome Res 10: 1788-1795
56. Wagner TE et al. (1981) Microinjection of a rabbit ?-globin gene into zygotes and its subsequent expression in adult mice and their offspring. Proc Natl Acad Sci USA 78: 6376-6380
57. Brinster RL et al. (1981) Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell 27: 223-231
58. Palmiter RD et al. (1982) Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300: 611-615
59. Palmiter RD et al. (1983) Metallothionein-human GH fusion genes stimulate growth of mice. Science 222: 809-814
60. Kopchick JJ et al. (1999) Transgenic models of growth hormone action. Annu Rev Nutr 19: 437-461
61. Chen WY et al. (1991) Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. Endocrinology 129: 1402-1408
62. Kopchick JJ (2003) Discovery and development of a new class of drugs: GH antagonists. J Endocrinol Invest 26: 16-26
63. Kopchick JJ et al. (2002) Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocr Rev 23: 623-646
64. Ristevski S (2005) Making better transgenic models: conditional, temporal, and spatial approaches. Mol Biotechnol 29: 153-163
65. Matsuda I and Aiba A (2004) Receptor knock-out and knock-in strategies. Methods Mol Biol 259: 379-390
66. Coschigano KT et al. (2003) Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144: 3799-3810
67. Yakar S et al. (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96: 7324-7329
68. Sjogren K et al. (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96: 7088-7092
69. Fire A et al. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811
70. Bernstein E et al. (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-366
71. Hammond SM et al. (2000) An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404: 293-296
72. Pham JW et al. (2004) A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila. Cell 117: 83-94
73. Ouellet DL et al. (2006) MicroRNAs in gene regulation: when the smallest governs it all. J Biomed Biotechnol 4: 1-20
74. Berget SM et al. (1977) Spliced segments at the 5′ terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci USA 74: 3171-3175
75. Berget SM and Sharp PA (1977) A spliced sequence at the 5'-terminus of adenovirus late mRNA. Brookhaven Symp Biol 29: 332-344
76. Sharp PA (2005) The discovery of split genes and RNA splicing. Trends Biochem Sciences 30: 279-281
77. McGarrity GJ (2004) SMaRT RNA therapy. Curr Drug Discov 4: 15-19
78. Valente L and Nishikura K (2005) ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog Nucleic Acid Res Mol Biol 79: 299-338
79. Garavelli JS (2003) The RESID Database of Protein Modifications: 2003 developments. Nucleic Acids Res 31: 499-501